Praveen Papareddy Selected Research

Thrombin

1/2012	Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis.
6/2011	Structure-activity studies and therapeutic potential of host defense peptides of human thrombin.
4/2010	Proteolysis of human thrombin generates novel host defense peptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Praveen Papareddy Research Topics

Disease

11	Infections 01/2018 - 09/2010
6	Shock 01/2016 - 04/2010
6	Sepsis (Septicemia) 01/2016 - 04/2010
5	Wounds and Injuries (Trauma) 01/2020 - 04/2010
4	Bacterial Infections (Bacterial Infection) 12/2019 - 01/2016
4	Inflammation (Inflammations) 01/2019 - 01/2012
3	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 04/2016
2	Pseudomonas Infections 01/2016 - 01/2014
2	Septic Shock (Toxic Shock Syndrome) 01/2016 - 05/2014
1	Asthma (Bronchial Asthma) 01/2019
1	Pneumococcal Infections 01/2019
1	Lung Injury 01/2019
1	Acute Lung Injury 01/2019
1	Gram-Negative Bacterial Infections 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Pneumonia (Pneumonitis) 01/2017
1	Neoplasms (Cancer) 01/2016
1	Necrotizing Fasciitis 12/2015
1	Hemolysis 04/2014
1	Leg Ulcer 09/2010
1	Neoplasm Metastasis (Metastasis) 04/2009
1	Prostatic Neoplasms (Prostate Cancer) 04/2009

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 01/2018 - 04/2010
4	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2018 - 01/2012
3	LipopolysaccharidesIBA 01/2019 - 04/2010
3	EndotoxinsIBA 01/2018 - 01/2012
3	FibrinIBA 01/2018 - 01/2012
3	CytokinesIBA 01/2014 - 01/2013
3	Thrombin FDA Link 01/2012 - 04/2010
2	OsteopontinIBA 01/2019 - 01/2019
2	Histones (Histone)IBA 01/2019 - 12/2015
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2018 - 09/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2014
2	Heparin Cofactor IIIBA 05/2014 - 01/2014
2	Antimicrobial Cationic PeptidesIBA 01/2012 - 04/2010
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2020
1	AntithrombinsIBA 12/2019
1	Protein Isoforms (Isoforms)IBA 12/2019
1	AllergensIBA 01/2019
1	AntigensIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	QuinolonesIBA 01/2017
1	EM703IBA 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	Deoxyribonucleases (DNase)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	LactamsIBA 01/2017
1	MacrolidesIBA 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2016
1	RoflumilastIBA 04/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2016
1	CoagulantsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Thromboplastin (Tissue Factor)IBA 01/2016
1	EpitopesIBA 01/2016
1	Antimicrobial PeptidesIBA 01/2016
1	Chemotactic FactorsIBA 12/2015
1	EnzymesIBA 04/2010
1	Hormones (Hormone)IBA 04/2009
1	adenovirus receptorIBA 04/2009
1	Green Fluorescent ProteinsIBA 04/2009

Therapy/Procedure

1	Therapeutics 04/2009